3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Carcinoma, Hepatocellular
5
Carcinoma, Renal Cell
4
Melanoma
2
Endometrial Neoplasms
2
von Hippel-Lindau Disease
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Hematologic Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Adenoid Cystic
1
Brain Neoplasms
1
Bone Neoplasms
1
Advanced Malignancies
1
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
1
Adenocarcinoma
1
Interventions
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
Doxorubicin
5
pembrolizumab
4
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Cyclophosphamide
4
liposomal doxorubicin
3
fludarabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
atezolizumab
2
anlotinib
2
Temozolomide
2
Radiation
2
Irinotecan
2
Ifosfamide
2
Carboplatin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
lenvatinib
×
30 days
×
Clear all
No trials found.